United States News Todas as matérias

Core Scientific (NASDAQ:CORZ) signaled a definitive departure from its identity as a pure-play cryptocurrency miner on Monday, announcing plans to sell nearly all of its remaining Bitcoin to finance a capital-intensive transition into artificial intelligence and high-performance computing (HPC).

Advantage Solutions (NASDAQ:ADV), a leading provider of outsourced sales, marketing and merchandising services to consumer goods manufacturers and retailers, on Tuesday reported fourth-quarter revenue of $932.1 million for the period ended December 31, 2025.

Passage Bio (NASDAQ:PASG) reported its full-year 2025 financial results on Tuesday, detailing a leaner operational structure and significant enrollment momentum for its lead gene therapy candidate in frontotemporal dementia.

Aurelion (NASDAQ:AURE) reported unaudited first-quarter 2026 results on Tuesday, unveiling a balance sheet now almost entirely defined by its new mandate as the first Nasdaq-listed treasury focused on Tether Gold (XAUt).

Marex Group (NASDAQ:MRX) reported record-breaking fourth-quarter and full-year 2025 results on Tuesday, as the diversified financial services platform leveraged a flurry of recent acquisitions and high client activity to extend its 11-year streak of sequential profit growth.

Upland Software (NASDAQ:UPLD) reported a modest fourth-quarter profit on Tuesday, but the cloud-based enterprise specialist issued a cautious 2026 revenue forecast that suggests a period of transition ahead for its software portfolio.

908 Devices (NASDAQ:MASS) reached a major financial milestone in the fourth quarter, reporting positive adjusted EBITDA and cash flow for the first time as the company’s high-margin recurring revenue began to scale.

Amylyx Pharmaceuticals (NASDAQ:AMLX) reported a significantly narrowed net loss for 2025 on Tuesday, as the company aggressively cut costs following its retreat from the ALS market and redirected capital toward its metabolic disease pipeline.

Ziff Davis (NASDAQ:ZD) announced Tuesday that it has reached a definitive agreement to divest its Connectivity business to Accenture in an all-cash transaction valued at $1.2 billion.

Prime Medicine (NASDAQ:PRME) reported full-year 2025 financial results on Tuesday, signaling a strategic shift toward commercial-stage readiness as its "search-and-replace" gene editing platform achieves its first human clinical validations.

Antalpha (NASDAQ:ANTA) posted an explosive fourth quarter on Tuesday, capitalizing on a sharp rise in institutional demand for Bitcoin-backed financing and a timely strategic bet on tokenized gold.

Oxford Square Capital reported a sharp decline in its Net Asset Value (NAV) for the fourth quarter on Tuesday, as significant unrealized depreciation in its investment portfolio overshadowed steady net investment income.

L.B. Foster (NASDAQ:FSTR) reported a mixed fourth quarter on Tuesday, as higher-than-expected revenue from its rail and infrastructure segments failed to translate into the bottom-line performance anticipated by Wall Street.

CalciMedica (NASDAQ:CALC) reported its full-year 2025 financial results on Tuesday, outlining a path forward for its lead candidate, Auxora™, despite the recent discontinuation of its primary kidney injury study.

SOPHiA GENETICS (NASDAQ:SOPH) reported a strong finish to its fiscal year on Tuesday, pairing double-digit revenue growth with significant margin expansion as the healthcare-tech firm moves closer to its goal of operational profitability.

Scholar Rock (NASDAQ:SRRK) reported a significant increase in annual spending on Tuesday, reflecting the heavy operational costs of transitioning from a purely clinical-stage firm to a commercial-ready biopharmaceutical entity.

Versant Media Group (NASDAQ:VSNT) marked its first full year as an independent company by initiating an aggressive capital return program, signaling confidence in its cash-generation even as it navigates a transition away from former parent Comcast.

Viking Holdings (NYSE:VIK) reported a surge in full-year profitability on Tuesday, bolstered by an aggressive fleet expansion and a luxury travel boom that has already filled the vast majority of its 2026 sailing schedule.

Best Buy (NYSE:BBY) reported fourth-quarter earnings that cleared Wall Street’s profitability hurdles on Tuesday, though a slight revenue miss highlighted the continued caution of consumers regarding big-ticket electronics.

AutoZone (NYSE:AZO) reported an 8.1% increase in second-quarter sales on Tuesday, as the company’s aggressive store expansion and inflation-driven pricing offset a dip in net income caused by technical accounting charges.

Kontoor Brands (NYSE:KTB) posted a sharp increase in fourth-quarter revenue on Tuesday, clearing the $1 billion threshold as the company reaps the benefits of its 2025 acquisition of Helly Hansen and continued momentum in its core denim business.

Sea Limited (NYSE:SE) capped a transformative fiscal year with a massive jump in bottom-line growth, signaling that the Southeast Asian internet giant has successfully pivoted from cash-burning expansion to a sustainable, high-margin model.

Target (NYSE:TGT) posted a solid fourth-quarter performance on Tuesday, as the big-box retailer leaned into its digital marketplace and subscription services to offset a broader slowdown in discretionary consumer spending.